Cited by 164Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchHealth, Environment, Cognitive Aging

The DOI matches its Crossref record; 264 of the 268 references it cites were found in a registry or an index.

Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine

Open access

Eid, Aseel, Mhatre, Isha, Richardson, Jason R.·2019·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2019.03.005PMC PMC6827882

Open this paper in CoChat — free account

Abstract

Alzheimer's disease (AD) is the leading cause of dementia in the United States and afflicts >5.7 million Americans in 2018. Therapeutic options remain extremely limited to those that are symptom targeting, while no drugs have been approved for the modification or reversal of the disease itself. Risk factors for AD including aging, the female sex, as well as carrying an APOE4 genotype. These risk factors have been extensively examined in the literature, while less attention has been paid to modifiable risk factors, including lifestyle, and environmental risk factors such as exposures to air pollution and pesticides. This review highlights the most recent data on risk factors in AD and identifies gene by environment interactions that have been investigated. It also provides a suggested framework for a personalized therapeutic approach to AD, by combining genetic, environmental and lifestyle risk factors. Understanding modifiable risk factors and their interaction with non-modifiable factors (age, susceptibility alleles, and sex) is paramount for designing personalized therapeutic interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2019.03.005

Cites

264 of 264 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Air pollution and health
Brunekreef, B., & Holgate, S. T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11274-8 · Cited by 4,701
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Impact of pesticides use in agriculture: their benefits and hazards
Aktar, M. W., Sengupta, D., & Chowdhury, A. (2009) · Interdisciplinary Toxicology · doi:10.2478/v10102-009-0001-7 · Cited by 3,588
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459

Flagged first, then by citations

Show all 268 references

4 of the 268 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–164 of 164

A causal inference study: The impact of the combined administration of Donepezil and Memantine on decreasing hospital and emergency department visits of Alzheimer’s disease patients
Yaghmaei, E., Pierce, A., Lu, H., Patel, Y. M., Ehwerhemuepha, L., Rezaie, A., Sajjadi, S. A., & Rakovski, C. S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291362 · Cited by 6
Sporadic Alzheimer’s Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss
Tsamou, M., Carpi, D., Pistollato, F., & Roggen, E. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215434 · Cited by 6
TREM2 R47H variant and risk for Alzheimer’s disease: assessment in a Greek population and updated meta-analysis
Rikos, D., Siokas, V., Mentis, A. A., Aloizou, A., Liampas, I., Tsouris, Z., Peristeri, E., Stamati, P., Hadjigeorgiou, G. M., & Dardiotis, E. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2150844 · Cited by 15
Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer’s Disease
Chauhan, S., Behl, T., Sehgal, A., Singh, S., Sharma, N., Gupta, S., Albratty, M., Najmi, A., Meraya, A. M., & Alhazmi, H. A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00621-4 · Cited by 6
The Association Between Herpes Zoster, Antiherpetic Therapies, and Alzheimer’s Disease: A Comprehensive Systematic Review
Alghamdi, A., Koen, E., Helmantel, M., Rafie, K., Dolga, A. M., Munster, B. C. V., & Hak, E. (2025) · Pharmaceuticals · doi:10.3390/ph18050722 · Cited by 5
Precision health in Alzheimer disease: Risk assessment‐based strategies
Azar, J., Salama, M., Chidambaram, S. B., Al‐Balushi, B., Essa, M. M., & Qoronfleh, M. W. (2021) · Precision Medical Sciences · doi:10.1002/prm2.12036 · Cited by 7
The impact of APOE ε4 in Alzheimer’s disease: a meta-analysis of voxel-based morphometry studiesPreprint
Bailey, M., Ilchovska, Z. G., Hosseini, A. A., & Jung, J. (2024) · medRxiv · doi:10.1101/2024.05.10.24307165 · Cited by 5
Cerebral blood flow alterations in the precuneus of Alzheimer's disease using arterial spin labeling: A systematic review and meta-analysis
Ghaderi, S., Mohammadi, S., & Fatehi, F. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111444 · Cited by 4
Exploring neuron-specific steroid synthesis and DHEAS therapy in Alzheimer's disease
Lin, H.-Y., Feng, Y., Kao, T., Chen, H.-C., Chen, G.-Y., Ko, C., & Hsu, T. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106585 · Cited by 4
Examining APOE ε4 and Longitudinal Vascular Brain Injury
Hayes, C. A., Odden, M. C., Levendovszky, S. R., Buchwald, D., Verney, S. P., Shibata, D. K., Zhang, Y., Ali, T., & Suchy‐Dicey, A. M. (2025) · Neurology Open Access · doi:10.1212/wn9.0000000000000059 · Cited by 3
Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities
Alameen, A. A. M., Al-Kuraishy, H. M., Abdelaziz, A. M., Al-Gareeb, A. I., Albuhadily, A. K., & Batiha, G. E. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124578 · Cited by 3
Trends in Alzheimer Disease Mortality Among American Indian and Alaska Native People Between 2011 and 2019
Amiri, S., Jiang, L., Manson, S. M., & Buchwald, D. (2023) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000555 · Cited by 3
Oral Microbiota in Patients with Alzheimer’s Disease: A Systematic Review
Pruntel, S. M., Leusenkamp, L. A., Zaura, E., Vissink, A., & Visser, A. (2024) · Applied Sciences · doi:10.3390/app14198869 · Cited by 3
Characterizing Frequency-Selective Network Vulnerability for Alzheimer's Disease by Identifying Critical Harmonic Patterns
Leinwand, B., Guorong Wu, A., & Pipiras, V. (2020) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi45749.2020.9098324 · Cited by 3
Epistatic Features and Machine Learning Improve Alzheimer’s Risk Prediction Over Polygenic Risk ScoresPreprint
Hermes, S., Cady, J., Armentrout, S. L., O’Connor, J., Carlson, S. E., Cruchaga, C., Wingo, T. S., Greytak, E. M., & Initiative, T. A. D. N. (2023) · medRxiv · doi:10.1101/2023.02.10.23285766 · Cited by 3
Ethical issues in genomics research in persons with Alzheimer’s Disease/Alzheimer’s Disease-related dementia (AD/ADRD): a systematic review
Yakubu, A., Adedeji, I. A., Maduka, O. C., Jegede, A. S., & Adebamowo, C. (2024) · BMC Medical Ethics · doi:10.1186/s12910-024-01141-w · Cited by 3
The role of genetic polymorphisms on drug response in Alzheimer’s disease: a systematic review
Climacosa, F. M. M., Ornos, E. D. B., Gapaz, N. C. L. L., Guantia, M. G. R., Cruz, J. M. C., Manalo, R. V. M., Yu, M. L., Qureshi, A. P., Carampel, A. C., Asis, J. L. B., et al. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02225-1 · Cited by 3
Tirzepatide attenuates neurotoxicity by suppressing inflammation, apoptosis and restoring neurotrophin expression in an Alzheimer’s disease-like rat model
Attia, M. S. M., Ahmad, S. F., Nadeem, A., Ansari, M. A., Al‐Hamamah, M. A., Harisa, G. I., Bakheet, S. A., Emran, T. B., Singh, T., & Attia, S. M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01870-4 · Cited by 3
The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer’s Disease
Migliorati, M., Manrique, C., Rahrah, M., Escoffier, G., Ahmadi, A. E., Girard, S. D., Khrestchatisky, M., Rivera, S., Baranger, K., & Roman, F. S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220281 · Cited by 2
Epigenetic regulons in Alzheimer's disease
Raval, M., Mishra, S., & Tiwari, A. K. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.01.012 · Cited by 2
Toward the Next Generation of Precision Medicine
Verhulst, B., & Benstock, S. E. (2023) · Policy Insights from the Behavioral and Brain Sciences · doi:10.1177/23727322231197765 · Cited by 2
The Indiscriminate Use of Pesticides could Increase the Prevalence of Alzheimer's Disease? A Systematic Review
Trevisan, K., Cristina-Pereira, R., Santos, B. R., Mendonça, P. E., da Silva, H. T., Gonçalves-Mendes, M. T., & Aversi‐Ferreira, T. A. (2024) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2024/v21i4441 · Cited by 2
A multi-ethnic proteomic profiling analysis in Alzheimer’s disease identifies the disparities in dysregulation of proteins and pathogenesis
Tan, M. S., Cheah, P., Chin, A., Looi, L., & Chang, S. (2024) · PeerJ · doi:10.7717/peerj.17643 · Cited by 2
SLC6A4 gene variants moderate associations between childhood food insecurity and adolescent mental health
Pilkay, S. R., Nolasco, M., Nunes, S., Riffer, A., Femia, D., Halevy, D., Veerman, T., Heiland, S., Suwannimit, N., Trexler, N., et al. (2024) · Brain and Behavior · doi:10.1002/brb3.3426 · Cited by 1
Understanding Interactions Between Life Satisfaction and Genetic Predisposition on Risk of Alzheimer's Disease up to 14 Years Later: Findings From the UK Biobank
John, A., Desai, R., Bartrés‐Faz, D., Cadar, D., Gaysina, D., Gonzalez, A. S., Marchant, N. L., Willroth, E. C., Richards, M., Saunders, R., et al. (2025) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70120 · Cited by 1
Impact of Manganese on Neuronal Function: An Exploratory Multi-Omics Study on Ferroalloy Workers in Brescia, Italy
Azmoun, S., Lewis, F. C., Shoieb, D., Jin, Y., Colicino, E., Mhatre‐Winters, I., Gu, H., Krishnamurthy, H. K., Richardson, J. R., Placidi, D., et al. (2025) · Brain Sciences · doi:10.3390/brainsci15080829 · Cited by 1
Self-citation
Sex differences in APOE- and PICALM-related cognitive profiles in healthy middle-aged adults
Bednorz, A., Trybek, P., Hoang, M. T., & Religa, D. (2026) · Frontiers in Aging · doi:10.3389/fragi.2025.1694701 · Cited by 1
Associations of air pollution and genetic risk and their interaction with risk of Alzheimer’s disease: identification of risk loci and potential biological pathways
Ran, S., Zhang, J., Cai, M., Chen, L., Qian, Z. M., Tian, F., Wu, G., Boyd, R., McMillin, S. E., Zeng, H.-C., et al. (2026) · GeroScience · doi:10.1007/s11357-026-02102-4 · Cited by 1
Regulatory Variation at TERT and TERC Shows Limited Association with Early-Onset Alzheimer’s Disease in Carriers of the Mexican Founder Mutation PSEN1 A431E
Gazcón-Rivas, C. P., Roa-Bruzón, I. Y., Almira, L. F. D., Valdez-Gaxiola, C. A., Dumois‐Petersen, S., Eduardo Figuera, L., Ramos, A. Q., Gurrola‐Díaz, C. M., Ortuño‐Sahagún, D., Valle, Y., et al. (2026) · Medical Sciences · doi:10.3390/medsci14020228 · Cited by 1
WSB. APP/PS1 mice develop age‐dependent cerebral amyloid angiopathy, cerebrovascular dysfunction, and white matter deficits
Marola, O. J., Uyar, A., Keezer, K. J., Chie, J. A. K. C., Elk, K. J., Cullen, A. E., Eldridge, K., Persohn, S. A., Kanyinda, J. N., Whitesell, J. D., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71476 · Cited by 2
Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells
Morsy, N., El‐Shiekh, R. A., Ebrahium, M. M., & Srour, A. M. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110245 · Cited by 1
Late Onset Alzheimer Dementia in Patients with Genotype E3/E4: A Case Report
Laksmidewi, A. A. A. P., & Rau, C. P. V. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.5583 · Cited by 1
The Use of Human and Animal Stem Cells as the Therapy of Neurodegeneration Diseases: Cells and Cells-free Therapy
Wihadmadyatami, H., & Kusindarta, D. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00120-7 · Cited by 1
Effects of Cognitive- and Sleep- Related Single Nucleotide Polymorphisms on Cognitive Functions in the Han Chinese Community-dwelling ElderlyPreprint
Li, J., Fu, J., Zheng, Z., Zhu, X., Han, X., & Li, J. (2020) · doi:10.21203/rs.3.rs-25884/v1 · Cited by 1
Can Brain Health Interventions Reduce Mexico’s Dementia Burden? An Essay
Vega, W. A., & Gutiérrez‐Robledo, L. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-70119-2_13
Epigenetic programming of human disease and aging
Rivero-Segura, N. A., Castro-Morales, D., Beristain-Pozos, J. D., Sandoval-Rodríguez, F. E., & Gómez-Verján, J. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-21863-7.00017-2
Integrated Transcriptomics and Network Analysis Identified Altered Neural Mechanisms in Frontal Aging Brain-Associated Alzheimer’s Disease
Chujan, S., Cholpraipimolrat, W., & Satayavivad, J. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10549-9
Predicting Alzheimer’s Trajectory: A Multi-PRS Machine Learning Approach for Early Diagnosis and Progression ForecastingPreprint
Mustaq, M., Ahmed, N., Mahbub, S., Li, C., Miyaoka, Y., Julia, T. C. W., Andrews, S. J., Bayzid, M. S., & Initiative, T. A. D. N. (2023) · medRxiv · doi:10.1101/2023.11.28.23299110
New Genetic Loci Discovery for Alzheimer’s Disease Using Explainable Deep Neural NetworksPreprint
Gkertsou, C., Parameshwarappa, A. K., Shiyanbola, A., Balkhiyarova, Z., Kouchaki, S., Prokopenko, I., Lagou, V., & Demirkan, A. (2023) · Preprints.org · doi:10.1101/2023.12.11.23299839
Insights into the Pathogenesis of Alzheimer’s Disease for Better Therapeutics
Agrawal, A., & Purushothaman, S. S. (2024) · Premier journal of science. · doi:10.70389/pjs.100042
Impact of Manganese on Neuronal Function: An Exploratory MultiOmic Study on Ferroalloy Workers in Brescia, ItalyPreprint
Azmoun, S., Lewis, F., Shoieb, D., Jin, Y., Colicino, E., Mhatre‐Winters, I., Gu, H., Krishnamurthy, H. K., Richardson, J. R., Placidi, D., et al. (2025) · medRxiv · doi:10.1101/2025.05.02.25326824
Self-citation
The ISN Neuroscience School, Ondo 2024, Gene–environment interactions in neurological disorders: a contemporary update
Anadu, V. E., Jimoh-Abdulghaffaar, H. O., Gilbert, T. T., Aneke, O. V., Arietarhire, L. O., Ichipi-Ifukor, P. C., Abdullahi, A. M., Okah, L., Sabine, A. F. Y., Oritsetimeyin, B. U., et al. (2025) · Biology Open · doi:10.1242/bio.061998
Human–Environment Interactions: A Multi-Omics and Interactome Perspective
Kanchan, S., Kesheri, M., Kaithal, P., Srivastava, U., Kaur, H., Pathak, J., & Sinha, R. P. (2025) · Springer eBooks · doi:10.1007/978-981-96-7067-3_12
Role and relation of cell death in Alzheimer’s disease
Hoang, D. A., Le, D. A., Do, T. M. H., & Than, V. T. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.06.024
Column Chromatography-based Isolation and Characterization of Bergapten and Gallic Acid from Angelica glauca Edgew. Roots and their Anti-Alzheimer’s Effect via Targeting Cholinesterase Enzymes
Mishra, A. K., & Paliwal, S. (2025) · Current Bioactive Compounds · doi:10.2174/0115734072393391250726183450
Neuroimaging Research in Alzheimer’s Disease Across Africa: A Systematic Bibliometric Review (1983–2024)Preprint
Nathaniel, M., Dauda, W. P., Abraham, P., Ogra, I. O., Jonathan, E. U., Usman, S., Luka, M. I., Glen, E., Daji, M., Ndukwe, J. K., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7915450/v1
Apolipoprotein E4 genotype in Moroccan patients with dementia
Razouqi, Y., Bouchikhi, I. E., El‐Abid, H., Mergaoui, M., Khalki, L., & Bouguenouch, L. (2025) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_349_2025
Additional file 1 of Genetic susceptibility and lifestyle modify the association of long-term air pollution exposure on major depressive disorder: a prospective study in UK Biobank
Li, D., Xie, J., Wang, L., Sun, Y., Hu, Y., & Tian, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22614409
Additional file 1 of Leading determinants of incident dementia among individuals with and without the apolipoprotein E ε4 genotype: a retrospective cohort study
Ye, S., Roccati, E., Wang, W., Zhu, Z., Kiburg, K., Huang, Y., Zhang, X., Zhang, X., Liu, J., Tang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25255773
Therapeutics immunotargets for Tauopathy
Chinnathambi, S., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.015
Suppression of haptoglobin and loss of striatal neurons in mice chronically exposed to chlorpyrifos-contaminated drinking water
Fikse, E. N., Anderson, F. L., Cho, S., Landry, J., Carloni, E., Biggs, K. E., Paul, K., Daley, T., Chang, T. Y., Kettenbach, A. N., et al. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag012
Maladaptive aging trajectory in late-onset Alzheimer's disease
Lv, T., Sun, H., Xia, T., Zhu, M. L., & Li, Y. (2026) · The Innovation Life · doi:10.59717/j.xinn-life.2026.100206
Étude du rôle de la microglie dans la propagation de la protéine Tau : mise en place de nouveaux modèles
Duwat, C. (2021) · theses.fr (ABES) · doi:10.70675/b4d3f614ze4bdz4745zb73cz5c7e662402bb
Integrating contextual determinants and polygenic risk to examine dementia and late‐life cognition in the Multi‐Ethnic Study of Atherosclerosis
Xue, D., Hirsch, J. A., Besser, L. M., Hughes, T. M., Blue, E. E., Fitzpatrick, A. L., & Fohner, A. E. (2026) · Alzheimer's & Dementia · doi:10.1002/alz.71384
Prenatal Pesticide Exposure and Early Alzheimer Disease-Related Biomarker and Cognitive Changes in MidlifePreprint
Mhatre‐Winters, I., Cirillo, P. M., Factor-Litvak, P. R., Han, Y., Krigbaum, N. Y., Zimmermann, L. M., Link, B. G., Go, Y., Jones, D. P., Cohn, B. A., et al. (2026) · medRxiv · doi:10.64898/2026.05.13.26352896
Self-citation
Potential biases associated with reported parental history of dementia in the Alzheimer's Disease Research Center cohorts: Implications for secondary data analyses
Guilliams, C., & Abner, E. L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261450630
Small Molecules as Anti-Alzheimer’s Scaffolds
Hazra, R., Roy, S., Gayen, S., Parui, A., Arshad, A., Roy, N., & Sarkar, A. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010013
Heterogeneity in the association between APOE ε4 carrier status and dementia risk by modifiable and non-modifiable risk factors
Zhang, M., Ho, F. K. W., Pell, J. P., Celis-Morales, C., Bailey, M. E. S., Strawbridge, R. J., & Lyall, D. M. (2026) · GeroScience · doi:10.1007/s11357-026-02452-z
Are mouse models of Alzheimer’s disease truly flawed, or are we misusing them?
Calon, F., Otaegui, L., Bouali, M. L., & Hébert, S. S. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.07.069
Utilizing routinely acquired clinical neuroimaging and electronic health record data to advance precision medicine in dementia care
Oishi, K., Adams, R., Nowrangi, M. A., Zandi, P. P., & Lyketsos, C. G. (2026) · International Review of Psychiatry · doi:10.1080/09540261.2026.2714142
Effect of dietary patterns on biomarkers in Alzheimer’s disease
Rezaeimanesh, N., Khodadadi, S., Montazeri‐Shatouri, R., Motahar, A. A., Hosseini, E., Owji, M., Negah, S. S., & Moghadasi, A. N. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.012
Cadmium exposure and incidence of all-cause dementia and Alzheimer's disease in US adults
Walker, E., Rodríguez‐Carmona, Y., Wang, X., Mukherjee, B., Merino, L., Hao, W., Dodge, H. H., Albin, R. L., Paulson, H. L., Park, S. K., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261487104
Epigenetics in Alzheimer’s disease: from molecular mechanisms to emerging novel biomarkers
D’Aversa, E., Grisafi, M., Pernagallo, S., Salvatori, F., Singh, A. V., Nucciarone, A., Tisato, V., & Gemmati, D. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1959361
Sex-specific personality metatrait profiles and their associations with APOE, PICALM variants, and cognitive performance in healthy middle-aged adults: a cluster-based analysis
Bednorz, A., & Religa, D. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1933176

Authors: Eid, A., Mhatre, I., & Richardson, J. R.
Affiliations: Florida International University (US)
Corresponding author: Richardson, Jason R.
ORCID: Richardson, Jason R.
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2019-07
Volume: 199
Pages: 173-187
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2019.03.005
PMC: PMC6827882
OpenAlex: W2922392851
Cited by: 164
References: 268
Citations by year: 2026: 21 · 2025: 28 · 2024: 34 · 2023: 20 · 2022: 15 · 2021: 13 · 2020: 24 · 2019: 9
FWCI: 1.80
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: NIH (R01ES021800, R01ES026057, R01ES026067-S2, U01NS108956)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
Keywords: Alzheimer's disease, gene-environment interaction, modifiable risk factors, lifestyle risk factors, air pollution exposure, pesticide exposure, APOE ε4, sex differences, aging, personalized medicine, precision medicine, dementia
MeSH terms: Alzheimer Disease, Animals, Humans, Risk Factors, Precision Medicine, Gene-Environment Interaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks